BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 22326395)

  • 1. Synthesis and biological evaluation of sulfonyl acrylonitriles as novel inhibitors to peritoneal carcinomatosis.
    Zificsak CA; Shen Y; Lisko JG; Theroff JP; Lao X; Bollt O; Li X; Dorsey BD; Kuwada SK
    Bioorg Med Chem Lett; 2012 Mar; 22(5):1850-3. PubMed ID: 22326395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, and biological evaluation of sulfonyl acrylonitriles as novel inhibitors of cancer metastasis and spread.
    Shen Y; Zificsak CA; Shea JE; Lao X; Bollt O; Li X; Lisko JG; Theroff JP; Scaife CL; Ator MA; Ruggeri BA; Dorsey BD; Kuwada SK
    J Med Chem; 2015 Feb; 58(3):1140-58. PubMed ID: 25581261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologic downregulation of c-FLIP(L) restores juxtacrine death receptor-mediated apoptosis in cancer cells in a peritoneal carcinomatosis model.
    Shen Y; Herde R; Doxey BW; Xu C; Gray PD; Kuwada SK
    Int J Cancer; 2012 Apr; 130(7):1494-503. PubMed ID: 21480219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of the peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy (IHPC): postoperative morbidity and mortality and short-term follow-up].
    Minicozzi A; Borzellino G; Momo EN; Segattini C; Pitoni F; Steccanella F; De Manzoni G
    Ann Ital Chir; 2008; 79(4):231-9. PubMed ID: 19093624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor beta1 produced in autocrine/paracrine manner affects the morphology and function of mesothelial cells and promotes peritoneal carcinomatosis.
    Na D; Lv ZD; Liu FN; Xu Y; Jiang CG; Sun Z; Miao ZF; Li F; Xu HM
    Int J Mol Med; 2010 Sep; 26(3):325-32. PubMed ID: 20664947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Solitary peritoneal carcinomatosis in prostate cancer].
    Brehmer B; Makris A; Wellmann A; Jakse G
    Aktuelle Urol; 2007 Sep; 38(5):408-9. PubMed ID: 17907070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colorectal cancer and peritoneal carcinomatosis.
    Cintron JR; Pearl RK
    Semin Surg Oncol; 1996; 12(4):267-78. PubMed ID: 8829286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraperitoneal administration of novel doxorubicin loaded polymeric delivery systems against peritoneal carcinomatosis: experimental study in a murine model of ovarian cancer.
    Colombo PE; Boustta M; Poujol S; Jarlier M; Bressolle F; Teulon I; Ladjemi MZ; Pinguet F; Rouanet P; Vert M
    Gynecol Oncol; 2011 Sep; 122(3):632-40. PubMed ID: 21665252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simvastatin reduces tumor cell adhesion to human peritoneal mesothelial cells by decreased expression of VCAM-1 and β1 integrin.
    Wagner BJ; Löb S; Lindau D; Hörzer H; Gückel B; Klein G; Glatzle J; Rammensee HG; Brücher BL; Königsrainer A
    Int J Oncol; 2011 Dec; 39(6):1593-600. PubMed ID: 21874229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phagocytosis of dying tumor cells by human peritoneal mesothelial cells.
    Wagner BJ; Lindau D; Ripper D; Stierhof YD; Glatzle J; Witte M; Beck H; Keppeler H; Lauber K; Rammensee HG; Königsrainer A
    J Cell Sci; 2011 May; 124(Pt 10):1644-54. PubMed ID: 21525033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carcinoma-associated fibroblasts derive from mesothelial cells via mesothelial-to-mesenchymal transition in peritoneal metastasis.
    Sandoval P; Jiménez-Heffernan JA; Rynne-Vidal Á; Pérez-Lozano ML; Gilsanz Á; Ruiz-Carpio V; Reyes R; García-Bordas J; Stamatakis K; Dotor J; Majano PL; Fresno M; Cabañas C; López-Cabrera M
    J Pathol; 2013 Dec; 231(4):517-31. PubMed ID: 24114721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cytoreductive surgery and intraperitoneal hyperthermic-antiblastic therapy (HAPP) in peritoneal carcinomatosis].
    Vaira M; Scuderi S; Costamagna D; Barone R; Aghemo B; Mioli PR; De Simone M
    Minerva Chir; 2002 Oct; 57(5):597-605. PubMed ID: 12370661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor activity of albendazole against the human colorectal cancer cell line HT-29: in vitro and in a xenograft model of peritoneal carcinomatosis.
    Pourgholami MH; Akhter J; Wang L; Lu Y; Morris DL
    Cancer Chemother Pharmacol; 2005 May; 55(5):425-32. PubMed ID: 15565325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The integrated treatment of peritoneal carcinomatosis. A preliminary experience.
    Cavaliere F; Di Filippo F; Cosimelli M; Aloe L; Arcuri E; Anzà M; Callopoli A; Di Lauro L; Morace E; Botti C; Natoli S; Tedesco M; Giunta S; Cavaliere R
    J Exp Clin Cancer Res; 1999 Jun; 18(2):151-8. PubMed ID: 10464701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arsenic trioxide (As(2)O(3)) inhibits peritoneal invasion of ovarian carcinoma cells in vitro and in vivo.
    Zhang J; Wang B
    Gynecol Oncol; 2006 Oct; 103(1):199-206. PubMed ID: 16624393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Peritoneal carcinomatosis].
    Coelho SS; Silva PM; Ramos J
    Acta Med Port; 1998 Jun; 11(6):585-9. PubMed ID: 9773541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of Peritoneal Carcinomatosis in Epithelial Ovarian Cancer: A Review.
    van Baal JOAM; van Noorden CJF; Nieuwland R; Van de Vijver KK; Sturk A; van Driel WJ; Kenter GG; Lok CAR
    J Histochem Cytochem; 2018 Feb; 66(2):67-83. PubMed ID: 29164988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Connective tissue growth factor acts as a therapeutic agent and predictor for peritoneal carcinomatosis of colorectal cancer.
    Lin BR; Chang CC; Chen RJ; Jeng YM; Liang JT; Lee PH; Chang KJ; Kuo ML
    Clin Cancer Res; 2011 May; 17(10):3077-88. PubMed ID: 21558398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility of using intraperitoneal epinephrine and cisplatin in patients with advanced peritoneal carcinomatosis.
    Molucon-Chabrot C; Isambert N; Benoit L; Zanetta S; Fraisse J; Guilland JC; Royer B; Monin-Baroille P; Flesch M; Fargeot P; Coudert B; Mayer F; Fumoleau P; Chauffert B
    Anticancer Drugs; 2006 Nov; 17(10):1211-7. PubMed ID: 17075321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraperitoneal treatment using taxol is effective for experimental peritoneal carcinomatosis in a rat model.
    Hribaschek A; Ridwelski K; Pross M; Meyer F; Kuhn R; Halangk W; Boltze C; Lippert H
    Oncol Rep; 2003; 10(6):1793-8. PubMed ID: 14534698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.